• Determination of conditions for optimum labeling of DOTA-Y3-Octreotate with terbium-161 [abstract] 

    Spatola, Bradley; Cutler, Cathy S.; Engelbrecht, Hendrik P.; Cantorias, Melchor V.; Somashekar, C. (University of Missouri--Columbia. Office of Undergraduate Research, 2007)
    DOTA-Y3-Octreotate (DOTA-TATE) and other somatostatin analogs can be labeled with radionuclides for cancer-fighting applications. Specifically, the radiolanthanides are of great interest to the radiopharmaceutical industry ...